Výsledky vyhledávání

Six-month leuprorelin acetate depot formulations in advanced prostate cancer: a clinical evaluation

Autor: Ulf W Tunn, Damian Gruca, Peter Bacher

Publikováno v: Clinical Interventions in Aging

For nearly three decades, gonadotropin-releasing hormone (GnRH) agonists, particularly leuprorelin acetate (LA), have served as an important part of the treatment armamentarium for prostate cancer. The introduction of LA depot formulations provided a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a9d66563c79ef6d10ba5372c12eb26b
http://europepmc.org/articles/PMC3639016

Zobrazit plný text záznamu

High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Clinically Localized Prostate Cancer: Treatment Evolution and Mature Results

Autor: Dimos Baltas, Thomas Martin, S. Papaioannou, Nikolaos Zamboglou, Thomas Buhleier, Hanns Ackermann, Natasa Milickovic, Ulf W. Tunn, Nikolaos Tselis

Publikováno v: International Journal of Radiation Oncology*Biology*Physics. 85:672-678

Purpose To report the clinical outcome of high-dose-rate (HDR) interstitial (IRT) brachytherapy (BRT) as sole treatment (monotherapy) for clinically localized prostate cancer. Methods and Materials Between January 2002 and December 2009, 718 consecut

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d8321de80981f3cefe4440b83a5b566
https://doi.org/10.1016/j.ijrobp.2012.07.004

Zobrazit plný text záznamu

Safety and tolerability of intermittent androgen deprivation therapy: A literature review

Autor: Damian Gruca, Peter Bacher, Ulf W Tunn

Publikováno v: International Journal of Urology. 19:614-625

Androgen deprivation therapy is commonly used in men with advanced prostate cancer; however, it is associated with many short- and long-term side-effects. Intermittent androgen deprivation therapy was first suggested as an alternative regimen in the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5d4d2b1b28f573c5a35af5f6ed144e5b
https://doi.org/10.1111/j.1442-2042.2012.03001.x

Zobrazit plný text záznamu

Transdifferentiation of Distal but Not Proximal Tubular Epithelial Cells from Human Kidney in Culture

Autor: Helmut Geiger, Jürgen E. Scherberich, Patrick C. Baer, German Nunez, Ulf W. Tunn

Publikováno v: Nephron Experimental Nephrology. 7:306-313

Human renal proximal and distal (thick ascending limb and early distal convoluted tubule) epithelial cells have been isolated according to their specific antigen expression. The cells were well characterized by flow cytometry, enzyme cytochemistry an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90322e27bae953b04bfd8a699ca0f366
https://doi.org/10.1159/000020618

Zobrazit plný text záznamu

Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases

Autor: Ulf W, Tunn, Amulf, Stenzl, Wolfgang, Schultze-Seemann, Arne, Strauss, Manfred, Kindler, Kurt, Miller, Manfred P, Wirth, Niko, Zantl, Matthias, Schulze, Christoph, May, Amelie, Ruebel, Katrin, Birkholz, Viktor, Gruenwald

Publikováno v: The Canadian journal of urology. 19(3)

Approximately 30% of patients with renal cell cancer (RCC) develop bone metastasis causing skeletal-related events (SRE): pathologic fracture, spinal cord compression, surgery to bone and radiotherapy. Zoledronic acid demonstrated significant clinica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::801ab99ee2230b4bfe3eb09ece719510
https://pubmed.ncbi.nlm.nih.gov/22704311

Zobrazit plný text záznamu

Efficacy and tolerability of 3- and 6-month depot formulations of leuprorelin acetate for advanced prostate cancer in treatment-naïve and pretreated patients: pooled data from two non-interventional studies

Autor: Ulf W. Tunn, Carsten Ohlmann, Marco Gross-Langenhoff

Publikováno v: Journal of Clinical Oncology. 33:e16098-e16098

e16098 Background: Androgen-deprivation therapy is the current standard therapy for advanced prostate cancer (PCa), primarily consisting of injections of luteinizing hormone-releasing hormone agoni...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::48fc6f606acccdd8ca221a09e59d49d4
https://doi.org/10.1200/jco.2015.33.15_suppl.e16098

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání